Home > News > WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
March 26th, 2004
WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
WallStreet Research led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an analyst research report initiating coverage of BioSante Pharmaceuticals, Inc. The complete analyst research report on BioSante Pharmaceuticals, Inc., together with the risks associated therewith and additional information about WallStreet Research is available online.
Aspen Aerogels, Inc. Schedules Second Quarter 2014 Earnings Release and Conference Call July 15th, 2014
Nanometrics to Announce Second Quarter Financial Results on July 30, 2014 July 9th, 2014
Small, but heading for the big time: Nanobiotix revenue for the 1st quarter of 2014 and new composition of the shareholding May 12th, 2014
Harris & Harris Group Reports Financial Statements as of March 31, 2014 May 8th, 2014